BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 19017556)

  • 21. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats.
    Pavlichenko N; Sokolova I; Vijde S; Shvedova E; Alexandrov G; Krouglyakov P; Fedotova O; Gilerovich EG; Polyntsev DG; Otellin VA
    Brain Res; 2008 Oct; 1233():203-13. PubMed ID: 18675258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells can affect solid organ allograft survival.
    Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.
    Giordano A; Galderisi U; Marino IR
    J Cell Physiol; 2007 Apr; 211(1):27-35. PubMed ID: 17226788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy.
    Zhang N; Li J; Luo R; Jiang J; Wang JA
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):104-11. PubMed ID: 18286426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases.
    Kan I; Melamed E; Offen D
    Handb Exp Pharmacol; 2007; (180):219-42. PubMed ID: 17554511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke.
    Hayase M; Kitada M; Wakao S; Itokazu Y; Nozaki K; Hashimoto N; Takagi Y; Dezawa M
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1409-20. PubMed ID: 19436312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain.
    Kim SS; Yoo SW; Park TS; Ahn SC; Jeong HS; Kim JW; Chang DY; Cho KG; Kim SU; Huh Y; Lee JE; Lee SY; Lee YD; Suh-Kim H
    Stem Cells; 2008 Sep; 26(9):2217-28. PubMed ID: 18617687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focused ultrasound-induced stimulation of microbubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction.
    Ghanem A; Steingen C; Brenig F; Funcke F; Bai ZY; Hall C; Chin CT; Nickenig G; Bloch W; Tiemann K
    J Mol Cell Cardiol; 2009 Sep; 47(3):411-8. PubMed ID: 19540842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of bone marrow-derived stem cells: a promising therapy for stroke.
    Tang Y; Yasuhara T; Hara K; Matsukawa N; Maki M; Yu G; Xu L; Hess DC; Borlongan CV
    Cell Transplant; 2007; 16(2):159-69. PubMed ID: 17474297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy.
    Zimmet JM; Hare JM
    Basic Res Cardiol; 2005 Nov; 100(6):471-81. PubMed ID: 16237508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction.
    Müller-Ehmsen J; Krausgrill B; Burst V; Schenk K; Neisen UC; Fries JW; Fleischmann BK; Hescheler J; Schwinger RH
    J Mol Cell Cardiol; 2006 Nov; 41(5):876-84. PubMed ID: 16973174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.
    Urbán VS; Kiss J; Kovács J; Gócza E; Vas V; Monostori E; Uher F
    Stem Cells; 2008 Jan; 26(1):244-53. PubMed ID: 17932424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
    Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
    Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune plasticity of bone marrow-derived mesenchymal stromal cells.
    Stagg J; Galipeau J
    Handb Exp Pharmacol; 2007; (180):45-66. PubMed ID: 17554504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human mesenchymal stem cell culture for neural transplantation.
    Gordon D; Scolding NJ
    Methods Mol Biol; 2009; 549():103-18. PubMed ID: 19378199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration.
    Zhang ZL; Tong J; Lu RN; Scutt AM; Goltzman D; Miao DS
    Bone Marrow Transplant; 2009 Jan; 43(1):69-81. PubMed ID: 18711348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
    Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural transdifferentiation of human bone marrow mesenchymal stem cells on hydrophobic polymer-modified surface and therapeutic effects in an animal model of ischemic stroke.
    Heo JS; Choi SM; Kim HO; Kim EH; You J; Park T; Kim E; Kim HS
    Neuroscience; 2013 May; 238():305-18. PubMed ID: 23454369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells and haematopoietic stem cell transplantation.
    Bacigalupo A
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):387-99. PubMed ID: 15498711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells for cardiac regenerative therapy.
    Schuleri KH; Boyle AJ; Hare JM
    Handb Exp Pharmacol; 2007; (180):195-218. PubMed ID: 17554510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.